Brooklyn ImmunoTherapeutics
Biopharmaceutical company focused on exploring effects of cytokine based therapies on cancer.
2
Funding Rounds
$33.2m
Money raised
Overview
Biopharmaceutical company focused on exploring effects of cytokine based therapies on cancer.
- Website:
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Gr***** Fi*** | - | - | |
| Ma** An*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ho**** J. Fe****** | - | - |
Funding series
Funding Series Analysis
The company Brooklyn ImmunoTherapeutics has raised a total of $12m in funding over 2 rounds.
Key Insights:
- Brooklyn ImmunoTherapeutics Funding Round, March 2022: $12m
- Brooklyn ImmunoTherapeutics Venture Funding Round November 2018: $21.2m
Brooklyn ImmunoTherapeutics Funding Round, March 2022
$12m
Brooklyn ImmunoTherapeutics Venture Funding Round November 2018
$21.2m
Industries
Brooklyn ImmunoTherapeutics is active in the following industries: